arXiv Machine Learning By Pedro Henrique da Costa Avelar, Le Ou-Yang, Min Wu, Sophia Tsoka

Biologically Informed Deep Neural Networks for Multi-Omic Integration, Pathway Activity Inference and Risk Stratification in Cancer

Read the original on arXiv Machine Learning →

arXiv:2607. 05306v1 Announce Type: new Abstract: Integrating complex, multi-omics data presents significant challenges.

Summary generated by The Flow from the publisher's feed. The full article lives at arXiv Machine Learning.

arXiv Machine Learning
Jun 2

Interpretable Graph Kolmogorov-Arnold Networks for Multi-Cancer Classification and Biomarker Identification using Multi-Omics Data

arXiv:2503. 22939v4 Announce Type: replace Abstract: The integration of heterogeneous multi-omics datasets at a systems level remains a central challenge for developing analytical and computational models in precision cancer diagnostics.

By Fadi Alharbi, Nishant Budhiraja, Aleksandar Vakanski, Boyu Zhang, Murtada K. Elbashir, Harshith Guduru, Mohanad Mohammed
arXiv AI
Aug 11

DoGMA: A Central-Dogma-Guided Foundation Model for Multi-Omics Alignment and Multi-Task Learning in Oncology

arXiv:2608. 08148v1 Announce Type: cross Abstract: Attention mechanisms have been widely utilized in modern deep learning, and many existing multi-omics models inherit their conventional use to allow unrestricted bidirectional interactions.

By Junfei Ling (Institute of Medical Robotics, Shanghai Jiao Tong University), Bangzheng Pu (Institute of Medical Robotics, Shanghai Jiao Tong University), Bingsen Xue (Institute of Medical Robotics, Shanghai Jiao Tong University), Tianle Li (Institute of Data Science, The University of Hong Kong), Ruying Hu (Oriental Pan-Vascular Devices Innovation College, University of Shanghai for Science and Technology), Cheng Jin (Institute of Medical Robotics, Shanghai Jiao Tong University)
arXiv Machine Learning
Jul 2

Explainable AI for Cancer Drug Response Prediction: Beyond Univariate Feature Attributions

arXiv:2607. 00931v1 Announce Type: new Abstract: Predicting cancer drug response from transcriptomic profiles is a cornerstone of precision oncology, yet the scientific value of machine learning models hinges not solely on predictive accuracy, but also on their capacity to generate reliable biological insights.

By Martino Ciaperoni, Margherita Lalli, Simone Piaggesi, Martina Varisco, Francesco Carli, Riccardo Guidotti, Dino Pedreschi, Francesco Raimondi, Fosca Giannotti